Molex posts
FeedPosted Feb 18th 2011 11:00AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Analyst Initiations
Analyst Upgrades
- Air Products (APD) to buy from hold at Deutsche Bank.
- Zimmer (ZMH) to outperform from neutral at RW Baird.
- SunPower (SPWRA) to buy from hold at Jefferies.
- Brocade (BRCD) to buy from hold at Wunderlich and at ThinkEquity.
- Duke Energy (DUK) to neutral from underperform at BofA/Merrill.
- NewStar Financial (NEWS) to outperform from market perform at Keefe Bruyette.
- Hormel Foods (HRL) to hold from sell at Soleil.
- Inspire Pharma (ISPH) to hold from sell at Duncan-Williams.
- Alnylam (ALNY) to buy from neutral at Roth Capital.
- Weight Watchers (WTW) to equal weight from underweight at Morgan Stanley.
- Raytheon (RTN) and Toreador Resources (TRGL) to outperform from sector perform at RBC Capital.
Continue reading Analyst Calls: BRCD, CREE, DUK, HRL, MOLX, RTN, SPWRA, VCLK, WTW ...
Posted Jan 18th 2011 11:30AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Yahoo! (YHOO), BP p.l.c. ADS (BP), Analyst Initiations
Analyst Upgrades
- BP (BP) to buy from hold at RBS.
- Symantec (SYMC) to buy from hold at Deutsche Bank.
- GenOn Energy (GEN) and Nationwide Health Properties (NHP) to buy from hold at Citigroup.
- Logitech (LOGI) and Patriot Coal (PCX) to neutral from sell, as well as ARM Holdings (ARMH) to buy from neutral, at Goldman.
- Silvercorp Metals (SVM) to outperform from market perform at BMO Capital.
- Cinemark (CNK) to equal weight from underweight at Morgan Stanley.
- Smith & Nephew (SNN) to market perform from underperform at Bernstein.
- Molex (MOLX) to overweight from underweight at JPMorgan.
Continue reading Analyst Calls: AB, ARMH, BP, DANG, JNS, LOGI, PCX, SYMC, YHOO, YOKU ...
Posted Oct 12th 2008 4:00PM by Steven Halpern (RSS feed)
Filed under: Newsletters, Presidential Elections, Stocks to Buy
This post is part of a series in which TheStockAdvisors.com asked financial experts to name their top stock pick if McCain or if Obama wins the election.
"A McCain victory would allow for a first year expensing of new equipment and technology; as such, we would recommend Molex (NASDAQ: MOLX), which is positioned in the technology value chain," says Thomas Vass in The Technology Stock Advisor.
"To provide an immediate boost to capital expenditures and reward investments in cutting edge technologies, John McCain would allow companies to expense the costs of new equipment or technology in the first year.
"High technology value chains -- such as computer and electronic equipment and information services -- are likely to benefit by this economic policy.
"Molex has an international value chain that will benefit greatly from the new policy because its customers will be able to buy technology goods at a much lower cost as a result of the new accelerated tax write-off.
"MOLX meets the Technology Stock Advisor screening criteria and has been in the TSA active portfolio since July of 2006. Standard & Poor's gives MOLX a B rating for quality. Our buy price target is $26. The target sell price is $40."
Steven Halpern's TheStockAdvisors.com offers a daily look at the latest market commentary and favorite stock picks and investment ideas from the nation's leading financial newsletter advisors.
Posted Oct 3rd 2008 9:30AM by Steven Halpern (RSS feed)
Filed under: Microsoft (MSFT), Apple Inc (AAPL), Time Warner (TWX), India, China, Brazil, Newsletters, Mutual Funds, Comcast Cl'A' (CMCSA), Merck and Co (MRK), Canada, , Barclays plc ADS (BCS), EOG Resources (EOG), Presidential Elections, Commodities, Oil, Agriculture, Stocks to Buy, Technology, General Dynamics Corp (GD), Israel, Green Stocks, Northrop Grumman (NOC)
Posted Aug 24th 2007 11:26AM by Kevin Shult (RSS feed)
Filed under: Before the Bell, Analyst Reports, Boston Scientific (BSX), Analyst Initiations, Stocks to Buy, Stocks to Sell
MOST NOTEWORTHY: Boston Scientific (BSX), Medtronic (MDT), St. Jude Medical (STJ), Bankrate (RATE) and AXA (AXA) were today's noteworthy initiations:
- Thomas Wiesel initiated coverage of the Medical Devices Industry:
- Boston Scientific (NYSE: BSX) was initiated with an Underweight rating, expecting shares to Underperform peers due to reductions in estimates, risks to the stent business and valuation.
- Medtronic (NYSE: MDT) was initiated with an Overweight rating, saying attractively valued as they believe the growth in underlying markets may be more robust than the current sentiment suggests.
- St. Jude Medical (NYSE: SJT) was initiated with an Overweight rating, saying shares offer exposure to attractive drivers, a management team with the best track record in the segment, and a potential acquisition candidate.
- Stephens believes the recent weakness in Bankrate (NASDAQ: RATE) due to "turmoil" in the market has created an attractive entry point, starting shares with an Overweight rating.
- Morgan Stanley assumed coverage of AXA (NYSE: AXA) with an Overweight rating, citing an attractive risk/reward and strong free cash flow...
OTHER INITIATIONS:
- S1 Corp (NASDAQ: SONE) was initiated with a Market Perform rating at Avondale.
- Credit Suisse initiated AK Steel (NYSE: AKS) with a Neutral rating.
- Jefferies started Molex (NASDAQ: MOLX) with a Hold rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).